ONCOSYNERGY
The vision of OncoSynergy, a UCSF spin-out, is to radically improve outcomes for patients with unmet needs in oncology with Resistance Mechanism Inhibitors (RMIs). This new class of therapeutics simultaneously targets multiple hallmarks of cancer progression and have demonstrated dramatic preclinical efficacy as monotherapy and in strategic combinations. It was founded in 2011 and is headquartered in Greenwich, Connecticut.
ONCOSYNERGY
Industry:
Biotechnology Health Care Therapeutics
Founded:
2011-01-01
Address:
Greenwich, Connecticut, United States
Country:
United States
Website Url:
http://www.oncosynergy.com
Total Employee:
1+
Status:
Active
Contact:
415-299-4249
Email Addresses:
[email protected]
Total Funding:
23.26 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Connecticut Innovations
Connecticut Innovations investment in Series A - OncoSynergy
NLabs
NLabs investment in Series A - OncoSynergy
Korea Information & Communication Co.
Korea Information & Communication Co. investment in Series A - OncoSynergy
Official Site Inspections
http://www.oncosynergy.com Semrush global rank: 4.47 M Semrush visits lastest month: 2.43 K
- Host name: 192.74.62.166.host.secureserver.net
- IP address: 166.62.74.192
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260